SEC Form 4 · accession 0001179110-17-003670
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen R Fussell
Officer — Executive Vice President
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 28, 2017 | F | 11,380 | $45.46 | D | 182,138 | D | |
| Common shares without par valueF1 | holding | — | — | — | 1,508 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 53 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2017.
- F2The reporting person disclaims beneficial ownership of all securities held by his spouse.